Kazia Therapeutics Limited(KZIA)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

KZIA Kazia Therapeutics Limited

未开盘 04-27 16:00:00 EDT

11.95

-0.31

-2.53%

盘后11.95

+0.000.00%

18:57 EDT

最高12.68	最低11.36	成交量24.22万
今开12.35	昨收12.26	日振幅10.74%
总市值1.37亿	流通市值1.26亿	总股本1,143万
成交额296.09万	换手率2.29%	流通股本1,058万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"KZIA","market":"US","secType":"STK","nameCN":"Kazia Therapeutics Limited","latestPrice":11.95,"timestamp":1777320000000,"preClose":12.26,"halted":0,"volume":242208,"hourTrading":{"tag":"盘后","latestPrice":11.95,"preClose":11.95,"latestTime":"18:57 EDT","volume":10,"amount":119.57,"timestamp":1777330649412,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.025285481239804283,"floatShares":10583400,"shares":11426899,"eps":-6.819035,"marketStatus":"未开盘","change":-0.31,"latestTime":"04-27 16:00:00 EDT","open":12.35,"high":12.68,"low":11.363,"amount":2960905.1207040004,"amplitude":0.107423,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-6.819035,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1777363200000},"marketStatusCode":0,"adr":0,"adrRate":500,"exchange":"NASDAQ","adjPreClose":12.26,"preHourTrading":{"tag":"盘前","latestPrice":12.33,"preClose":12.26,"latestTime":"09:29 EDT","volume":288,"amount":3537.36,"timestamp":1777296599999,"change":0.07,"changeRate":0.00571,"amplitude":0.027732},"postHourTrading":{"tag":"盘后","latestPrice":11.95,"preClose":11.95,"latestTime":"18:57 EDT","volume":10,"amount":119.57,"timestamp":1777330649412,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.585596,"impliedVol":2.1531,"impliedVolPercentile":0.6129},"requestUrl":"/m/hq/s/KZIA","defaultTab":"news","newsList":[{"id":"1159941648","title":"Kazia Therapeutics Limited董事会主席Bryce Carmine宣布将于2026年3月26日退休","url":"https://stock-news.laohu8.com/highlight/detail?id=1159941648","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1159941648?lang=zh_cn&edition=full","pubTime":"2026-04-01 18:08","pubTimestamp":1775038094,"startTime":"0","endTime":"0","summary":"2026年3月26日，Kazia Therapeutics Limited现任董事会主席Bryce Carmine正式向董事会通报其退休意向。这一重大人事变动标志着公司治理层即将迎来新的篇章。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","KZIA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1130524236","title":"Kazia Therapeutics拟募资2亿美元 通过ADS增发加速抗癌药物研发","url":"https://stock-news.laohu8.com/highlight/detail?id=1130524236","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1130524236?lang=zh_cn&edition=full","pubTime":"2026-03-18 18:09","pubTimestamp":1773828564,"startTime":"0","endTime":"0","summary":"澳大利亚生物技术公司Kazia Therapeutics Limited近日向美国证券交易委员会提交F-1表格，计划通过发行美国存托凭证募集最多2亿美元资金。根据备案文件，此次发行可能包括代表普通股的ADS或认股权证，具体条款尚未最终确定。Kazia此次募资规模相当于其当前市值的3倍以上，凸显其急需资金推进关键临床试验。若此次发行顺利完成，Kazia将获得足够资金支撑paxalisib未来18-24个月的临床开发。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","KZIA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614886557","title":"Kazia Therapeutics Limited盘中异动 早盘大幅上涨5.13%报7.99美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2614886557","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614886557?lang=zh_cn&edition=full","pubTime":"2026-02-26 23:10","pubTimestamp":1772118659,"startTime":"0","endTime":"0","summary":"北京时间2026年02月26日23时10分，Kazia Therapeutics Limited股票出现波动，股价大幅拉升5.13%。截至发稿，该股报7.99美元/股，成交量3.4724万股，换手率0.31%，振幅8.36%。Kazia Therapeutics Limited股票所在的生物技术行业中，整体跌幅为1.99%。Kazia Therapeutics Limited公司简介：Kazia Therapeutics Ltd是一家专注于肿瘤药物开发的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026022623105997a72fc6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026022623105997a72fc6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","NVGNF","KZIA","BK4539","BK4007","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2612146763","title":"Kazia Therapeutics Limited盘中异动 临近午盘急速拉升5.59%报5.29美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2612146763","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2612146763?lang=zh_cn&edition=full","pubTime":"2026-02-18 00:33","pubTimestamp":1771346025,"startTime":"0","endTime":"0","summary":"北京时间2026年02月18日00时33分，Kazia Therapeutics Limited股票出现波动，股价快速拉升5.59%。截至发稿，该股报5.29美元/股，成交量3.5977万股，换手率0.32%，振幅6.30%。Kazia Therapeutics Limited股票所在的生物技术行业中，整体涨幅为0.25%。Kazia Therapeutics Limited公司简介：Kazia Therapeutics Ltd是一家专注于肿瘤药物开发的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026021800334597a66892&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026021800334597a66892&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NVGNF","BK4139","KZIA","LENZ","BK4539","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1112652718","title":"Kazia Therapeutics公布核内Pd-L1降解剂Ndl2引人注目的临床前及转化研究数据","url":"https://stock-news.laohu8.com/highlight/detail?id=1112652718","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1112652718?lang=zh_cn&edition=full","pubTime":"2026-01-30 21:02","pubTimestamp":1769778174,"startTime":"0","endTime":"0","summary":"Kazia Therapeutics Limited (简称Kazia) 近日发布了其核内Pd-L1降解剂候选药物Ndl2的最新研究进展。数据显示，该药物在临床前及转化研究阶段展现出令人鼓舞的潜力。\n研究结果突显了Ndl2在靶向核内Pd-L1蛋白降解方面的独特机制。这些发现为后续开发提供了坚实的科学依据，并预示着该疗法在相关疾病领域可能具有重要的应用价值。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","KZIA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1124170363","title":"Kazia Therapeutics Limited 目标在2026年底前招募12名三阴性乳腺癌患者，并于2027年初公布顶线数据","url":"https://stock-news.laohu8.com/highlight/detail?id=1124170363","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1124170363?lang=zh_cn&edition=full","pubTime":"2026-01-27 21:02","pubTimestamp":1769518977,"startTime":"0","endTime":"0","summary":"Kazia Therapeutics Limited 已设定明确目标，计划在2026年年底前完成12名三阴性乳腺癌（TNBC）患者的入组工作。这项临床研究的顶线数据预计将在2027年初揭晓，标志着该药物研发项目的一个重要里程碑。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KZIA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1199188637","title":"Kazia Therapeutics在晚期转移性三阴性乳腺癌Paxalisib一期B阶段研究中报告积极初步临床反应","url":"https://stock-news.laohu8.com/highlight/detail?id=1199188637","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1199188637?lang=zh_cn&edition=full","pubTime":"2026-01-27 21:01","pubTimestamp":1769518875,"startTime":"0","endTime":"0","summary":"Kazia Therapeutics Limited（简称：Kazia）在其针对晚期转移性三阴性乳腺癌患者开展的Paxalisib药物一期B阶段临床研究中，公布了令人鼓舞的初步临床反应数据。该研究目前仍在进行中，最新结果显示Paxalisib在治疗这一难治型癌症方面展现出潜在疗效。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","KZIA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2586491079","title":"Kazia Therapeutics Limited盘中异动 股价大跌7.78%","url":"https://stock-news.laohu8.com/highlight/detail?id=2586491079","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586491079?lang=zh_cn&edition=full","pubTime":"2025-11-24 23:49","pubTimestamp":1763999395,"startTime":"0","endTime":"0","summary":"北京时间2025年11月24日23时49分，Kazia Therapeutics Limited股票出现异动，股价急速跳水7.78%。截至发稿，该股报7.70美元/股，成交量3.1636万股，换手率1.89%，振幅6.57%。Kazia Therapeutics Limited股票所在的生物技术行业中，整体涨幅为0.79%。Kazia Therapeutics Limited公司简介：Kazia Therapeutics Ltd是一家专注于肿瘤的生物技术公司，开发抗癌药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511242349569517c089&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511242349569517c089&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KZIA","NVGNF","BK4007","LENZ","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518222567","title":"Kazia Therapeutics Limited盘中异动 早盘股价大跌5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518222567","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518222567?lang=zh_cn&edition=full","pubTime":"2025-03-10 21:36","pubTimestamp":1741613793,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日21时36分，Kazia Therapeutics Limited股票出现波动，股价大幅下挫5.08%。截至发稿，该股报1.12美元/股，成交量19.3999万股，换手率3.47%，振幅5.08%。Kazia Therapeutics Limited股票所在的生物技术行业中，整体涨幅为0.42%。Kazia Therapeutics Limited公司简介：Kazia Therapeutics Ltd是一家专注于肿瘤的生物技术公司，开发抗癌药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213633abf2fe3e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213633abf2fe3e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","KZIA","NVGNF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517161311","title":"Kazia Therapeutics Limited盘中异动 大幅拉升7.33%报0.848美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517161311","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517161311?lang=zh_cn&edition=full","pubTime":"2025-03-06 22:59","pubTimestamp":1741273143,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日22时59分，Kazia Therapeutics Limited股票出现波动，股价急速拉升7.33%。截至发稿，该股报0.848美元/股，成交量1165股，换手率0.02%，振幅7.33%。Kazia Therapeutics Limited股票所在的生物技术行业中，整体跌幅为0.63%。Kazia Therapeutics Limited公司简介：Kazia Therapeutics Ltd是一家专注于肿瘤的生物技术公司，开发抗癌药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306225903abeb7e9d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306225903abeb7e9d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","NVGNF","KZIA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517948806","title":"Kazia Therapeutics Limited盘中异动 股价大涨6.06%报0.810美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517948806","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517948806?lang=zh_cn&edition=full","pubTime":"2025-03-05 22:32","pubTimestamp":1741185143,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日22时32分，Kazia Therapeutics Limited股票出现异动，股价大幅拉升6.06%。截至发稿，该股报0.810美元/股，成交量4.5971万股，换手率0.82%，振幅0.00%。Kazia Therapeutics Limited股票所在的生物技术行业中，整体涨幅为0.20%。Kazia Therapeutics Limited公司简介：Kazia Therapeutics Ltd是一家专注于肿瘤的生物技术公司，开发抗癌药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305223223abe9b0fa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305223223abe9b0fa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KZIA","NVGNF","LENZ","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517833819","title":"Kazia Therapeutics Limited盘中异动 急速下跌5.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517833819","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517833819?lang=zh_cn&edition=full","pubTime":"2025-03-05 03:33","pubTimestamp":1741116814,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日03时33分，Kazia Therapeutics Limited股票出现波动，股价大幅跳水5.16%。Kazia Therapeutics Limited股票所在的生物技术行业中，整体涨幅为0.04%。其相关个股中，Cyclacel Pharmaceuticals Inc 6% Cnv Pfd Usd、Rapport Therapeutics, Inc.、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 涨幅较大，Aeon Biopharma, Inc.、Protagenic Therapeutics, Inc.、Windtree Therapeutics, Inc.较为活跃，换手率分别为1311.19%、1224.04%、1209.16%，振幅较大的相关个股有Cyclacel Pharmaceuticals Inc 6% Cnv Pfd Usd、Protagenic Therapeutics Inc C/Wts 29/04/2026 、Plus Therapeutics, Inc.，振幅分别为122.48%、68.89%、68.09%。Kazia Therapeutics Limited公司简介：Kazia Therapeutics Ltd是一家专注于肿瘤的生物技术公司，开发抗癌药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305033334a25f57f2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305033334a25f57f2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KZIA","NVGNF","LENZ","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514861729","title":"Kazia Therapeutics Limited盘中异动 急速上涨5.62%报0.864美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514861729","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514861729?lang=zh_cn&edition=full","pubTime":"2025-02-27 03:38","pubTimestamp":1740598693,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日03时38分，Kazia Therapeutics Limited股票出现异动，股价急速上涨5.62%。截至发稿，该股报0.864美元/股，成交量3.8845万股，换手率0.69%，振幅5.28%。Kazia Therapeutics Limited股票所在的生物技术行业中，整体跌幅为0.47%。Kazia Therapeutics Limited公司简介：Kazia Therapeutics Ltd是一家专注于肿瘤的生物技术公司，开发抗癌药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502270338139631862c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502270338139631862c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NVGNF","LENZ","BK4139","KZIA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514016510","title":"Kazia Therapeutics Limited盘中异动 早盘股价大跌8.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514016510","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514016510?lang=zh_cn&edition=full","pubTime":"2025-02-25 23:30","pubTimestamp":1740497415,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日23时30分，Kazia Therapeutics Limited股票出现异动，股价大幅下跌8.34%。Kazia Therapeutics Limited股票所在的生物技术行业中，整体涨幅为0.78%。其相关个股中，Organovo Holdings, Inc.、Silexion Therapeutics Corp、Abpro Holdings Inc C/Wts 12/11/2029 涨幅较大，Gt Biopharma, Inc.、Organovo Holdings, Inc.、Moleculin Biotech, Inc.较为活跃，换手率分别为1070.68%、947.53%、593.23%，振幅较大的相关个股有Organovo Holdings, Inc.、Adial Pharmaceuticals, Inc、Silexion Therapeutics Corp，振幅分别为121.95%、64.05%、61.16%。Kazia Therapeutics Limited公司简介：Kazia Therapeutics Ltd是一家专注于肿瘤的生物技术公司，开发抗癌药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225233015a253950e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225233015a253950e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NVGNF","LENZ","BK4139","KZIA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512348187","title":"Kazia Therapeutics Limited盘中异动 急速下跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512348187","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512348187?lang=zh_cn&edition=full","pubTime":"2025-02-20 00:02","pubTimestamp":1739980942,"startTime":"0","endTime":"0","summary":"北京时间2025年02月20日00时02分，Kazia Therapeutics Limited股票出现异动，股价急速下挫5.00%。Kazia Therapeutics Limited股票所在的生物技术行业中，整体涨幅为0.46%。其相关个股中，Osr Holdings, Inc.、Osr Holdings Inc C/Wts 02/09/2028 、Neurosense Therapeutics Ltd C/Wts 10/11/2026 涨幅较大，Aditxt, Inc.、Alzamend Neuro, Inc.、Osr Holdings, Inc.较为活跃，换手率分别为561.88%、242.60%、178.48%，振幅较大的相关个股有Osr Holdings Inc C/Wts 02/09/2028 、Osr Holdings, Inc.、Aditxt, Inc.，振幅分别为207.68%、159.49%、48.18%。Kazia Therapeutics Limited公司简介：Kazia Therapeutics Ltd是一家专注于肿瘤的生物技术公司，开发抗癌药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250220000223a24c0cd1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250220000223a24c0cd1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NVGNF","BK4139","KZIA","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512659401","title":"Kazia Therapeutics Limited盘中异动 早盘大幅上涨7.81%报0.960美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512659401","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512659401?lang=zh_cn&edition=full","pubTime":"2025-02-18 22:32","pubTimestamp":1739889178,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日22时32分，Kazia Therapeutics Limited股票出现异动，股价大幅上涨7.81%。截至发稿，该股报0.960美元/股，成交量9723股，换手率0.17%，振幅3.31%。Kazia Therapeutics Limited股票所在的生物技术行业中，整体涨幅为0.11%。Kazia Therapeutics Limited公司简介：Kazia Therapeutics Ltd是一家专注于肿瘤的生物技术公司，开发抗癌药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218223258a24aad04&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218223258a24aad04&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NVGNF","KZIA","BK4139","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511216696","title":"Kazia Therapeutics Limited盘中异动 早盘股价大涨5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511216696","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511216696?lang=zh_cn&edition=full","pubTime":"2025-02-14 22:36","pubTimestamp":1739543819,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日22时36分，Kazia Therapeutics Limited股票出现异动，股价快速拉升5.14%。截至发稿，该股报0.988美元/股，成交量1.2669万股，换手率0.23%，振幅4.65%。Kazia Therapeutics Limited股票所在的生物技术行业中，整体涨幅为0.24%。Kazia Therapeutics Limited公司简介：Kazia Therapeutics Ltd是一家专注于肿瘤的生物技术公司，开发抗癌药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214223700a2460274&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214223700a2460274&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","KZIA","NVGNF","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511529687","title":"Kazia Therapeutics Limited盘中异动 股价大跌5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511529687","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511529687?lang=zh_cn&edition=full","pubTime":"2025-02-13 23:00","pubTimestamp":1739458823,"startTime":"0","endTime":"0","summary":"北京时间2025年02月13日23时00分，Kazia Therapeutics Limited股票出现异动，股价急速跳水5.09%。截至发稿，该股报0.930美元/股，成交量4.1444万股，换手率0.74%，振幅5.09%。Kazia Therapeutics Limited股票所在的生物技术行业中，整体涨幅为0.17%。Kazia Therapeutics Limited公司简介：Kazia Therapeutics Ltd是一家专注于肿瘤的生物技术公司，开发抗癌药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250213230023a244b255&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250213230023a244b255&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NVGNF","LENZ","BK4139","KZIA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510380367","title":"Kazia Therapeutics Limited盘中异动 早盘快速上涨5.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2510380367","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510380367?lang=zh_cn&edition=full","pubTime":"2025-02-11 22:33","pubTimestamp":1739284397,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日22时33分，Kazia Therapeutics Limited股票出现异动，股价大幅拉升5.56%。Kazia Therapeutics Limited股票所在的生物技术行业中，整体跌幅为0.95%。其相关个股中，Ocean Biomedical Inc C/Wts 14/02/2028 、In8Bio, Inc.、Lipella Pharmaceuticals Inc.涨幅较大，Lipella Pharmaceuticals Inc.、Ocean Biomedical, Inc.、In8Bio, Inc.较为活跃，换手率分别为1977.67%、528.53%、177.48%，振幅较大的相关个股有In8Bio, Inc.、Akari Therapeutics Plc、Lipella Pharmaceuticals Inc.，振幅分别为25.06%、16.07%、16.06%。Kazia Therapeutics Limited公司简介：Kazia Therapeutics Ltd是一家专注于肿瘤的生物技术公司，开发抗癌药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211223318a241fb85&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211223318a241fb85&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","NVGNF","KZIA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510486654","title":"Kazia Therapeutics Limited盘中异动 早盘股价大涨5.35%报1.33美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510486654","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510486654?lang=zh_cn&edition=full","pubTime":"2025-02-10 22:32","pubTimestamp":1739197934,"startTime":"0","endTime":"0","summary":"北京时间2025年02月10日22时32分，Kazia Therapeutics Limited股票出现波动，股价快速拉升5.35%。截至发稿，该股报1.33美元/股，成交量2.6946万股，换手率0.48%，振幅4.90%。Kazia Therapeutics Limited股票所在的生物技术行业中，整体涨幅为0.33%。Kazia Therapeutics Limited公司简介：Kazia Therapeutics Ltd是一家专注于肿瘤的生物技术公司，开发抗癌药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210223215961e0002&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210223215961e0002&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","NVGNF","KZIA"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.kaziatherapeutics.com","stockEarnings":[{"period":"1week","weight":0.1392},{"period":"1month","weight":0.669},{"period":"3month","weight":0.6713},{"period":"6month","weight":0.554},{"period":"1year","weight":2.283},{"period":"ytd","weight":0.7344}],"compareEarnings":[{"period":"1week","weight":0.0091},{"period":"1month","weight":0.1279},{"period":"3month","weight":0.0283},{"period":"6month","weight":0.0404},{"period":"1year","weight":0.2988},{"period":"ytd","weight":0.0488}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Kazia Therapeutics Limited成立于1994年3月，注册地为澳大利亚新南威尔士州。该公司从事药物开发，主要专注于肿瘤学。Kazia是一家新兴的生物技术企业，拥有涵盖多种技术的开发候选产品组合，旨在推进针对各种癌症适应症的创新疗法，并提供解决未满足的医疗需求的新疗法。","yearOnYearQuotes":[{"month":1,"riseRate":0.481481,"avgChangeRate":0.051769},{"month":2,"riseRate":0.285714,"avgChangeRate":0.031553},{"month":3,"riseRate":0.5,"avgChangeRate":0.046817},{"month":4,"riseRate":0.428571,"avgChangeRate":0.023902},{"month":5,"riseRate":0.296296,"avgChangeRate":-0.02903},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.056841},{"month":7,"riseRate":0.37037,"avgChangeRate":0.010347},{"month":8,"riseRate":0.407407,"avgChangeRate":0.002958},{"month":9,"riseRate":0.481481,"avgChangeRate":-0.003545},{"month":10,"riseRate":0.37037,"avgChangeRate":-0.038599},{"month":11,"riseRate":0.481481,"avgChangeRate":0.165037},{"month":12,"riseRate":0.407407,"avgChangeRate":-0.048165}],"exchange":"NASDAQ","name":"Kazia Therapeutics Limited","nameEN":"Kazia Therapeutics Limited"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Kazia Therapeutics Limited(KZIA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Kazia Therapeutics Limited(KZIA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Kazia Therapeutics Limited,KZIA,Kazia Therapeutics Limited股票,Kazia Therapeutics Limited股票老虎,Kazia Therapeutics Limited股票老虎国际,Kazia Therapeutics Limited行情,Kazia Therapeutics Limited股票行情,Kazia Therapeutics Limited股价,Kazia Therapeutics Limited股市,Kazia Therapeutics Limited股票价格,Kazia Therapeutics Limited股票交易,Kazia Therapeutics Limited股票购买,Kazia Therapeutics Limited股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Kazia Therapeutics Limited(KZIA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Kazia Therapeutics Limited(KZIA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}